ONE NATIONAL VISION. ONE COORDINATED EFFORT.

KidsCan Foundation brings together clinical expertise, research innovation, and national coordination to accelerate access to personalized precision-based pediatric cancer care in Switzerland.

HOW WE WORK

Our strategic portfolio

Coordination

Coordination

Create national center

Connect pediatric care, research, and collaboration.

Fund infrastructure & expertise

Build long-term Swiss pediatric oncology capacity and unified data-sharing. Attract and support talent.

Facilitate global network

Partner with top pediatric hospitals worldwide.

Precision & Research

Precision & Research

Promote precision medicine

Tailor personalized, precision-based pediatric diagnostics and therapies for each child.

Advance translational research

Develop novel pediatric cancer treatments.

Enable clinical trials

Participate in and lead international clinical studies.

Advocacy & Impact

Advocacy & Impact

Advocacy & education

Raise awareness of the impact of cutting-edge pediatric cancer care.

Following the initiative of Prof. Jean-Pierre Bourquin and Prof. Raffaele Renella, University Children's Hospitals Zurich (KISPI) und Lausanne (CHUV)

FUNDING FRAMEWORK
What we fund
Early Detection & Precision Diagnosis
Funding a proactive approach to stop cancer before it takes hold.
Next-Generation Treatments & Immunotherapy
Funding smarter, less toxic cures tailored to the individual child.
Data, AI & Smart Medicine
Funding the technological infrastructure for faster and smarter decisions.
Patient Access, Care & Future Leadership
Ensuring no child is left behind and building the future of pediatric oncology.
WHY PRECISION & PERSONALIZED MEDICINE
Personalized, precision-based medicine tailors treatment to the unique biology of each child's cancer. It allows clinicians to:
Choose therapies with the highest chance of success
Avoid ineffective and toxic treatments
Reduce long-term side effects
Improve survival and quality of life
PRECISION. EFFECTIVENESS. HUMANITY.
Precision medicine allows doctors to understand the unique biology of each child's cancer and tailor treatment accordingly. By matching therapies to the specific characteristics of the disease, we aim to improve outcomes while reducing unnecessary toxicity.